Giuseppe DAncona
Overview
Explore the profile of Giuseppe DAncona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAncona G, Savardi M, Massussi M, van der Valk V, Scherptong R, Signoroni A, et al.
J Thorac Dis
. 2024 Sep;
16(8):4914-4923.
PMID: 39268143
Background: The hypothesis that a deep learning (DL) model can produce long-term prognostic information from chest X-ray (CXR) has already been confirmed within cancer screening programs. We summarize our experience...
2.
Agma H, Krull A, Feickert S, Ammareen R, Ince H, DAncona G
Rev Cardiovasc Med
. 2024 Jul;
23(10):349.
PMID: 39077143
Aortic valve stenosis (AVS) is the most frequent valvular heart disease in industrialized countries, presenting with very high mortality if left untreated. While drug treatment can sometimes alleviate symptoms, it...
3.
Feickert S, Ewertsen N, Kobe J, Kleemann T, Jehle J, Senges J, et al.
J Thorac Dis
. 2024 Apr;
16(3):1825-1835.
PMID: 38617758
Background: Atrial fibrillation (AF) is a cardiac arrhythmia frequently documented in patients requiring implantable cardioverter defibrillators (ICDs) and/or cardiac resynchronization therapy with defibrillator (CRT-D). Patients with diagnosed AF at the...
4.
DAmario D, Meerkin D, Restivo A, Ince H, Sievert H, Wiese A, et al.
Eur J Heart Fail
. 2023 Apr;
25(6):902-911.
PMID: 37092287
Aims: In heart failure (HF), implantable haemodynamic monitoring devices have been shown to optimize therapy, anticipating clinical decompensation and preventing hospitalization. Direct left-sided haemodynamic sensors offer theoretical benefits beyond pulmonary...
5.
DAncona G, Massussi M, Savardi M, Signoroni A, Di Bacco L, Farina D, et al.
Int J Cardiol
. 2022 Nov;
370:435-441.
PMID: 36343794
Background: The predictive role of chest radiographs in patients with suspected coronary artery disease (CAD) is underestimated and may benefit from artificial intelligence (AI) applications. Objectives: To train, test, and...
6.
Baudo M, DAncona G, Trinca F, Rosati F, Di Bacco L, Curnis A, et al.
Int J Cardiol
. 2022 Jun;
363:80-86.
PMID: 35764203
Background: Atrioventricular node ablation (AVNA) and pacemaker (PM) is performed in symptomatic atrial fibrillation (AF) unresponsive to medical treatment and percutaneous ablation. This meta-analysis evaluated results after AVNA and PM....
7.
Rosati F, Baudo M, DAncona G, Tomasi C, Zanin F, Cuko B, et al.
J Cardiovasc Surg (Torino)
. 2022 Jun;
63(5):606-613.
PMID: 35758087
Background: Unenhanced chest CT can identify incidental findings (IFs) leading to management strategy change. We report our institutional experience with routine chest-CT as preoperative screening tool during the COVID-19 pandemic,...
8.
Perl L, Meerkin D, DAmario D, Ben Avraham B, Ben Gal T, Weitsman T, et al.
J Card Fail
. 2022 Jan;
28(6):963-972.
PMID: 35041933
Objective: Patients with heart failure (HF) are at an increased risk of hospital admissions. The aim of this report is to describe the feasibility, safety and accuracy of a novel...
9.
DAncona G, Arslan F, Safak E, Weber D, Ammareen R, Ince H
Int J Cardiol
. 2021 Dec;
351:61-64.
PMID: 34929249
Aims: Comparing actual management costs in patients with non-valvular atrial fibrillation (AF) treated with percutaneous left atrial appendage closure (LAAC) or OAC only. Methods And Results: Patients undergoing percutaneous LAAC...
10.
Feickert S, Ewertsen N, DAncona G, Oner A, Ince H, Ortak J
Internist (Berl)
. 2021 Nov;
63(2):230-237.
PMID: 34762155
Background: Patients with atrial fibrillation are at a significantly increased risk of thromboembolic events, especially ischemic strokes. Oral anticoagulation reduces this risk, but cannot be used in some patients for...